Pneumococcal Infections
📧 Sign up to get email alerts when something new happens for Pneumococcal Infections.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-09-18Clinical Trial Update: Immunogenicity and Safety of 23-valent Pneumococcal Polysaccharide Vaccine [Phase 4]
Phase 4 trial update evaluating immunogenicity and safety of the 23-valent pneumococcal polysaccharide vaccine.
-
CLINICAL_TRIALS trial_result · 2023-09-18Clinical Trial Update: Lot-to-lot Consistency of 23-valent Pneumococcal Polysaccharide Vaccine [Phase 4]
Phase 4 trial update assessing lot-to-lot consistency of the 23-valent pneumococcal polysaccharide vaccine.
-
EMA approval · 2023-05-24EMA Authorised: Synflorix (Pneumococcal polysaccharide serotype 23F;Pneumococcal polysaccharide serotype 4;Pneumococcal polysaccharide serotype 5;Pneumococcal polysaccharide serotype 6B;Pneumococcal polysaccharide serotype 7F;Pneumococcal polysaccharide serotype 9V;Pneumococcal polysaccharide serotype 1;Pneumococcal polysaccharide serotype 14;Pneumococcal polysaccharide serotype 18C;Pneumococcal polysaccharide serotype 19F) — GlaxoSmithKline Biologicals S.A.
EMA has authorised Synflorix, a pneumococcal conjugate vaccine by GlaxoSmithKline Biologicals S.A., for immunization against multiple pneumo…
-
CLINICAL_TRIALS trial_result · 2023-05-03Clinical Trial Update: Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-025) [Phase 3]
Phase 3 trial assessing safety, tolerability, and immunogenicity of the pneumococcal vaccine V114 in healthy infants has completed with resu…
-
CLINICAL_TRIALS trial_result · 2023-03-15Clinical Trial Update: Concomitant Administration of the Novavax Vaccine and a 20-valent Pneumococcal Conjugate Vaccine in Adults Aged ≥60 Years [Phase 4]
Phase 4 trial update evaluating concomitant administration of the Novavax COVID-19 vaccine with a 20-valent pneumococcal conjugate vaccine i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-12-01Clinical Trial Update: Safety, Tolerability, and Immunogenicity of a 3-dose Regimen of V114 in Healthy Infants (PNEU-PED-EU-2/V114-026) [Phase 3]
Phase 3 trial update on a 3-dose V114 regimen in healthy infants assessing safety, tolerability, and immunogenicity; results posted after co…
-
CLINICAL_TRIALS trial_result · 2022-11-15Clinical Trial Update: Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Healthy Japanese Infants (V114-033) [Phase 3]
Phase 3 trial evaluating safety, tolerability, and immunogenicity of V114 in healthy Japanese infants has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-10-20Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Allogeneic Hematopoietic Stem Cell Transplant Recipients (V114-022/PNEU-STEM) [Phase 3]
Phase 3 trial evaluating safety, tolerability, and immunogenicity of V114 in allogeneic hematopoietic stem cell transplant recipients has co…
-
CLINICAL_TRIALS trial_result · 2022-08-12Clinical Trial Update: A Clinical Trial of 23-valent Pneumococcal Polysaccharide Vaccine [Phase 4]
A Phase 4 trial update of the 23-valent pneumococcal polysaccharide vaccine sponsored by Sinovac Biotech has completed.
-
CLINICAL_TRIALS trial_result · 2022-05-10Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of V114 and Prevnar 13™ in Healthy Infants (V114-031/PNEU-LINK) [Phase 3]
Phase 3 trial assessing safety and tolerability of V114 with Prevnar 13 in healthy infants; study completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-03-25Clinical Trial Update: Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-029) [Phase 3]
Phase 3 trial update assessing safety, tolerability, and immunogenicity of V114 in healthy infants; results completed with posted findings i…
-
CLINICAL_TRIALS trial_result · 2021-12-09Clinical Trial Update: Safety and Immunogenicity of V114 in Children Infected With Human Immunodeficiency Virus (HIV) (V114-030/PNEU-WAY PED) [Phase 3]
Phase 3 trial assessing safety and immunogenicity of the PCV20-like vaccine V114 in children with HIV; study completed with results posted i…
-
CLINICAL_TRIALS trial_result · 2021-11-30Clinical Trial Update: Study to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Vaccine Given With Prevnar 13 in Healthy Infants [Phase 2]
Phase 2 study evaluating safety and immunogenicity of a multivalent pneumococcal vaccine with Prevnar 13 in healthy infants; study terminate…
-
CLINICAL_TRIALS trial_result · 2021-09-23Clinical Trial Update: Safety and Immunogenicity of Catch-up Vaccination Regimens of V114 (V114-024) [Phase 3]
Phase 3 trial update evaluating safety and immunogenicity of catch-up vaccination regimens for V114; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-08-23Clinical Trial Update: A Study to Evaluate the Interchangeability of V114 and Prevnar 13™ in Healthy Infants (V114-027/PNEU-DIRECTION) [Phase 3]
Phase 3 trial evaluating interchangeability of V114 and Prevnar 13 in healthy infants has completed; results were posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-08-10Clinical Trial Update: Immunity to Serotype 19A Streptococcus Pneumoniae in Children Vaccinated With PCV10
A completed clinical trial evaluating immune response to serotype 19A Pneumococcus in children vaccinated with PCV10.
-
CLINICAL_TRIALS trial_result · 2021-06-16Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Children With Sickle Cell Disease (V114-023/PNEU-SICKLE) [Phase 3]
Phase 3 trial evaluating safety, tolerability, and immunogenicity of V116 in children with sickle cell disease has completed; results posted…
-
CLINICAL_TRIALS trial_result · 2021-05-06Clinical Trial Update: Immunogenicity After Revaccination With 23-valent Pneumococcal Polysaccharide Vaccine: Healthy Elderly People Versus Diabetic Patients [Phase 4]
Phase 4 clinical trial comparing immunogenicity after revaccination with the 23-valent pneumococcal polysaccharide vaccine between healthy e…
-
CLINICAL_TRIALS research · 2021-05-06Clinical Trial Update: Safety and Immunogenicity Following Meningococcal and Pneumococcal Immunization Among Adult People Living With HIV [Phase 4]
Phase 4 trial assessing safety and immunogenicity of meningococcal and pneumococcal vaccination in adults living with HIV.
-
CLINICAL_TRIALS trial_result · 2021-04-12Clinical Trial Update: Lot-to-Lot Consistency of V114 in Healthy Adults (V114-020) [Phase 3]
Phase 3 trial updating lot-to-lot consistency of V114 in healthy adults has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-03-18Clinical Trial Update: Safety and Immunogenicity of V114 in Healthy Adults (V114-019/PNEU-AGE) [Phase 3]
Phase 3 trial update reporting safety and immunogenicity data for V114 in healthy adults (Pneumococcal infections).
-
CLINICAL_TRIALS trial_result · 2021-03-02Clinical Trial Update: Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Vaccine in Healthy Infants [Phase 2]
Phase 2 trial update on safety and immunogenicity of a multivalent pneumococcal vaccine in healthy infants completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-01-15Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by PNEUMOVAX™23 in Adults at Increased Risk for Pneumococcal Disease (V114-017/PNEU-DAY) [Phase 3]
Phase 3 trial evaluating safety, tolerability, and immunogenicity of V114 followed by PNEUMOVAX23 in adults at increased risk for pneumococc…
-
CLINICAL_TRIALS trial_result · 2021-01-06Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by PNEUMOVAX™23 in Healthy Adults 50 Years of Age or Older (V114-016/PNEU-PATH) [Phase 3]
Phase 3 trial assessing safety, tolerability, and immunogenicity of V114 followed by PNEUMOVAX23 in adults 50+ completed; results posted in …
-
CLINICAL_TRIALS trial_result · 2020-11-25Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by PNEUMOVAX™23 in Adults Infected With Human Immunodeficiency Virus (HIV) (V114-018) [Phase 3]
A Phase 3 study evaluating the safety, tolerability, and immunogenicity of V114 followed by PNEUMOVAX23 in adults with HIV; trial completed …